Trademark: 79200241
Word
HYALO
Status
Registered
Status Code
700
Status Date
Tuesday, June 26, 2018
Serial Number
79200241
Registration Number
5499777
Registration Date
Tuesday, June 26, 2018
Mark Type
5
Filing Date
Friday, July 29, 2016
Published for Opposition
Tuesday, April 10, 2018

Trademark Owner History
Fidia Farmaceutici S.p.A. - Original Registrant

Classifications
5 Pharmaceutical preparations for dermatological and gynecological use; pharmaceutical preparations for use during general, abdominal, gynecologic, cardiac, spine, tendon and peripheral nerve surgery; pharmaceutical preparations for the prevention of post-operative adhesions; dietary supplements for humans; plasters, materials for dressings; parapharmaceutical preparations for dermatological and gynecological use; anti-itch creams, gels and sprays for external use; antipruritics; lubricants for use with condoms; vaginal moisturizers; vaginal washes; personal sexual lubricants; antiseptics; detergents for medical use; pomades for medical use; tissues or gauzes impregnated with antibacterial preparations, with medical creams or medical lotions for orthopedic and dermatological purposes, for wound healing and tissue repair; creams, sprays, lotions or gels for dermatological purposes, for wound healing and tissue repair; pharmaceutical preparations for the treatment of the mouth and teeth; minerals for medical use; vitamins; dietetic and nutritional supplements
10 Apparatus for medical imaging; surgical equipment for wound treatment; suture materials; medical devices for suture and wound closing; cutaneous, ophthalmic and intra-articular applicators for the administration of pharmaceutical preparations; applicators in the form of inhalers and injection devices for the administration of pharmaceutical preparations, namely, injection and infusion devices, needle-based and needle-free injection systems and syringes
Color is not claimed as a feature of the mark.

Trademark Events
Jan 23, 2017
New Application Office Supplied Data Entered
Jan 12, 2017
Sn Assigned For Sect 66a Appl From Ib
Jan 19, 2017
Limitation From Original Application Entered
Jan 23, 2017
Assigned To Examiner
Jan 27, 2017
Application Filing Receipt Mailed
Jan 30, 2017
Non-Final Action Written
Jan 31, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Jan 31, 2017
Refusal Processed By Mpu
Jan 31, 2017
Non-Final Action Mailed - Refusal Sent To Ib
Feb 18, 2017
Refusal Processed By Ib
Jul 31, 2017
Teas Response To Office Action Received
Jul 31, 2017
Correspondence Received In Law Office
Aug 1, 2017
Teas/Email Correspondence Entered
Aug 23, 2017
Non-Final Action Written
Aug 23, 2017
Notification Of Non-Final Action E-Mailed
Aug 23, 2017
Non-Final Action E-Mailed
Nov 27, 2017
Assigned To Examiner
Feb 22, 2018
Teas Response To Office Action Received
Feb 22, 2018
Correspondence Received In Law Office
Feb 23, 2018
Teas/Email Correspondence Entered
Mar 7, 2018
Examiners Amendment E-Mailed
Mar 7, 2018
Examiners Amendment -Written
Mar 7, 2018
Examiner's Amendment Entered
Mar 7, 2018
Notification Of Examiners Amendment E-Mailed
Mar 21, 2018
Notification Of Notice Of Publication E-Mailed
Jun 14, 2018
Notification Of Possible Opposition Sent To Ib
Mar 7, 2018
Approved For Pub - Principal Register
Mar 21, 2018
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 21, 2018
Notification Of Possible Opposition Sent To Ib
Apr 6, 2018
Notification Processed By Ib
Apr 10, 2018
Published For Opposition
Apr 10, 2018
Official Gazette Publication Confirmation E-Mailed
Jun 14, 2018
Notification Of Possible Opposition Created, To Be Sent To Ib
Jun 26, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jun 26, 2024
Teas Section 71 Received
Jun 4, 2022
New Representative At Ib Received
Jun 26, 2018
Registered-Principal Register
Jun 29, 2018
Notification Of Possible Opposition - Processed By Ib
Sep 26, 2018
Final Disposition Notice Created, To Be Sent To Ib
Sep 26, 2018
Final Disposition Processed
Sep 27, 2018
Final Disposition Notice Sent To Ib
Oct 19, 2018
Final Decision Transaction Processed By Ib

Trademark Alertz updated from USPTO on 2030-01-24